| item
|
?artLink
|
description
|
| Q4626498
|
2012 Pakistan fake medicine crisis
|
Health scandal and drug fraud in Pakistan in point in time and point in time
|
| Q20707431
|
Naproxen/diphenhydramine
|
combination drug
|
| Q4736570
|
Alternative treatments used for the common cold
|
Common cold treatment
|
| Q30315102
|
Analgecine
|
analgesic
|
| Q19903309
|
Anthrax immune globulin
|
antibody and blood-derived medicine
|
| Q28209512
|
Antibiotic use in dentistry
|
medications used in dentistry and periodontics and antibiotic
|
| Q4774595
|
Anticestodal agent
|
anthelmintic
|
| Q4774738
|
Antigen-presenting cell vaccine
|
vaccine and vaccine type
|
| Q4774941
|
Antimicrotubule agent
|
mitotic inhibitor
|
| Q809940
|
Base analog
|
antimetabolite
|
| Q48996825
|
Beta-2 adrenergic antagonist
|
antagonist and class of chemical entities with similar applications or functions
|
| Q48968782
|
Beta-3 adrenergic antagonist
|
antagonist and class of chemical entities with similar applications or functions
|
| Q112120783
|
Brontex
|
ambroxol and medicinal product by Ratiopharm
|
| Q5019573
|
Calf lymph
|
vaccine and vaccine type
|
| Q25099825
|
Chloride channel blocker
|
channel blocker and class of chemical entities with similar applications or functions
|
| Q5104300
|
Cholecystokinin antagonist
|
antagonist and class of chemical entities with similar applications or functions
|
| Q5127988
|
Class II bacteriocin
|
bacteriocin and group or class of proteins
|
| Q5156356
|
Competitive antagonist
|
antagonist
|
| Q5173294
|
Corticotropin-releasing hormone antagonist
|
antagonist and class of chemical entities with similar applications or functions
|
| Q5173300
|
Cortifoam
|
Pharmaceutical product
|
| Q107404450
|
Crohns MAP Vaccine
|
viral vector vaccine
|
| Q127691319
|
Dapagliflozin/sitagliptin
|
medication
|
| Q5259401
|
Dental antibiotic prophylaxis
|
antibiotic prophylaxis and Antibiotic use in dentistry
|
| Q1752431
|
Dental dam (oral sex)
|
Contraceptive
|
| Q28163637
|
Dextran 70
|
medication and essential medicine
|
| Q5309812
|
Dryvax
|
vaccine and vaccine type
|
| Q115555736
|
Elontril
|
Pharmaceutical product
|
| Q5383701
|
Epithelial sodium channel blocker
|
channel blocker and class of chemical entities with similar applications or functions
|
| Q5444389
|
Fermented wheat germ extract
|
dietary supplement
|
| Q55613028
|
Group B streptococcus vaccine
|
Streptococcal vaccines
|
| Q55613291
|
Haemophilus B and hepatitis B vaccine
|
Bivalent vaccine and vaccine type
|
| Q5731795
|
Hepatitis A and typhoid vaccine
|
vaccine and vaccine type
|
| Q5774182
|
Historical annual reformulations of the influenza vaccine
|
influenza vaccine and vaccine type
|
| Q5953026
|
HybriCell
|
vaccine and vaccine type
|
| Q6058681
|
Testosterone (patch)
|
Pharmaceutical product
|
| Q123677462
|
Inverse vaccine
|
vaccine
|
| Q28209385
|
Kalicludine
|
channel blocker and protein family found in Snakelocks anemone
|
| Q16915769
|
Live vector vaccine
|
vaccine and vaccine type
|
| Q96390598
|
Living medicine
|
biopharmaceutical
|
| Q6719125
|
MVA-B
|
HIV vaccine and vaccine type
|
| Q116812795
|
Male birth control pill
|
male contraceptive
|
| Q6811647
|
Melatonin receptor agonist
|
chronobiotic, antidepressant, and drug class
|
| Q16251461
|
Mumpsvax
|
mumps vaccine and vaccine type
|
| Q130343832
|
NBI-1117568
|
antipsychotics
|
| Q17637123
|
NGR-hTNF (antitumor recombinant protein)
|
Recombinant protein and medication
|
| Q6960844
|
Naldecon
|
brand and medication
|
| Q7030571
|
Nicotine nasal spray
|
nasal sprays
|
| Q19362232
|
Non-competitive antagonist
|
antagonist
|
| Q18354395
|
Norepinephrine–dopamine releasing agent
|
Releasing agent and class of chemical entities with similar applications or functions
|
| Q7098746
|
Optaflu
|
influenza vaccine and vaccine type by Novartis
|
| Q7099412
|
Oral vaccination against rabies
|
rabies vaccine and vaccine type
|
| Q17075433
|
PneumoADIP
|
vaccine and vaccine type
|
| Q7246687
|
ProSavin
|
experimental drug
|
| Q1135452
|
Psychoanaleptic
|
Central nervous system agent and analeptic
|
| Q1351110
|
Remune
|
vaccine, vaccine type, and HIV/AIDS, from 1987
|
| Q7353181
|
Robitussin
|
mojo, brand, and medication
|
| Q3381667
|
SAV001
|
HIV vaccine and vaccine type
|
| Q7389150
|
SCIB1
|
vaccine and vaccine type
|
| Q7455039
|
Serostim
|
Pharmaceutical product
|
| Q18357107
|
Serotonin–dopamine releasing agent
|
Releasing agent and class of chemical entities with similar applications or functions
|
| Q24975675
|
Steroidal aromatase inhibitor
|
aromatase inhibitors, steroid, and class of chemical entities with similar applications or functions
|
| Q18393148
|
Swaim's Panacea
|
medication, named after William Swaim
|
| Q7690604
|
Tcelna
|
vaccine and vaccine type
|
| Q4455455
|
Theraflu
|
mojo and brand
|
| Q7783884
|
Thiazide-like diuretic
|
diuretic
|
| Q96409943
|
Tissue-selective estrogen complex
|
combination drug
|
| Q7824863
|
Topical irritation agents
|
counterirritant
|
| Q2106483
|
Trachitol
|
medication and cough drop in Netherlands, from 1960
|
| Q7838633
|
Treo (drug)
|
medication
|
| Q115937507
|
Triple dye
|
antiseptic
|
| Q7844782
|
TroVax
|
Vaccine candidate, cancer vaccine, vaccine type, and article
|
| Q19362259
|
Uncompetitive antagonist
|
antagonist
|
| Q7907692
|
VZV immune globulin
|
antibody and medication
|
| Q7907953
|
Vaccine failure
|
vaccine
|
| Q17014824
|
Vaginal estrogen
|
estrogen and class of chemical entities with similar applications or functions
|
| Q7925475
|
Vicks Sinex
|
brand and pharmaceutical product, part of Vicks
|
| Q349395
|
Yu Yee oil
|
ointment and topical medication
|
| Q25047876
|
Zzzquil
|
sedative and brand, from 2012
|
| Q4738284
|
Alvircept sudotox
|
medication and recombinant protein
|
| Q4774671
|
Antidepressants in Japan
|
antidepressant and aspect in a geographic region in Japan
|
| Q5456317
|
List of antiretroviral fixed-dose combinations
|
Fixed combination
|
| Q16858617
|
Cell-based vaccine
|
vaccine and vaccine type
|
| Q1171125
|
Compound spirit of ether
|
medication, named after Friedrich Hoffmann
|
| Q2608633
|
Drugs for acid-related disorders
|
medication and mucosal protective agent
|
| Q3716907
|
Dynepo
|
hormone
|
| Q65087024
|
Elapegademase
|
medication
|
| Q1431381
|
Ganglionic blocker
|
medication
|
| Q5747312
|
Heterologous vaccine
|
vaccine and vaccine type
|
| Q16965066
|
Liposomal daunorubicin
|
medication and mixture
|
| Q48834769
|
Loteprednol etabonate
|
medication
|
| Q130492383
|
External condom
|
condom
|
| Q6806661
|
Medications used in dentistry and periodontics
|
medication
|
| Q110872885
|
Model-Informed Precision Dosing
|
medication
|
| Q85787775
|
Narrow-spectrum antibiotic
|
antibiotic
|
| Q7050950
|
Norepinephrine–dopamine disinhibitor
|
medication and class of chemical entities with similar applications or functions
|
| Q29898848
|
Oral rehydration solution
|
drink, rehydration solution, medication, and essential medicine
|
| Q55629500
|
Peroxide-based bleach
|
bleach
|
| Q7199029
|
Pitrakinra
|
Recombinant protein and medication
|
| Q7201521
|
Plant expressed vaccine
|
vaccine and vaccine type
|
| Q7232121
|
Portmanteau inhibitor
|
reaction inhibitor, medication, group or class of chemical substances, and HIV/AIDS
|
| Q7234686
|
Potassium binder
|
medication and Antihyperkalemic Agents
|
| Q7251503
|
Protein supplement
|
dietary supplement
|
| Q5940878
|
Recombinant factor VIIa
|
Recombinant protein and medication
|
| Q7522394
|
Sinecatechins
|
medication
|
| Q2294895
|
Small modular immunopharmaceutical
|
Recombinant protein, immunopharmaceutical, and group or class of proteins
|
| Q7553300
|
Sodium cellulose phosphate
|
medication
|
| Q2772241
|
Therapeutic window
|
research, medication, pharmacology, and toxicity
|
| Q7824862
|
Topical anesthetic
|
local anesthetic
|
| Q7852675
|
Tumor antigen vaccine
|
vaccine and vaccine type
|
